HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use North American Coral Snake Antivenin (Equine) safely and effectively. See full prescribing information for North American Coral Snake Antivenin (Equine). North American Coral Snake Antivenin (Equine) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1967 INDICATIONS AND USAGENorth American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snakes - Micrurus. (1) DOSAGE AND ADMINISTRATIONFor intravenous use only.
DOSAGE FORMS AND STRENGTHSLyophilized powder in single use vial for reconstitution for injection. (3) CONTRAINDICATIONS
WARNINGS AND PRECAUTIONSPatients sensitive to North American Coral Snake Antivenin (Equine) or horse serum may develop anaphylaxis. Prior to intravenous North American Coral Snake Antivenin (Equine) administration consider performing a proper skin test and modify therapy if indicated. (5.1) ADVERSE REACTIONSAdverse reactions may include anaphylaxis and serum sickness, vomiting, and abdominal pain. (6) To report SUSPECTED ADVERSE REACTIONS, contact Pfizer, Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. See 17 for PATIENT COUNSELING INFORMATION. Revised: 7/2019 |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
ANTIVENIN®(micrurus fulvius)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
ANTIVENIN® Quick Finder
To interact with the Medical Information Digital Assistant click here.
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch